Summit Biosciences Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
99
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
Summit Biosciences General Information
Description
Developer of a specialized pharmaceutical platform designed to focus on developing, manufacturing, and commercializing generic and innovative nasal spray medicines. The company's platform offers unit-dose, nasal spray products with the development of pre-filled, disposable, intranasal spray products, enabling clients to address and meet important needs for the management of chronic and acute care conditions.
Contact Information
Website
www.summitbiosciences.comCorporate Office
- UK Coldstream Research Campus
- 1513 Bull Lea Road
- Lexington, KY 40511
- United States
Corporate Office
- UK Coldstream Research Campus
- 1513 Bull Lea Road
- Lexington, KY 40511
- United States
Summit Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Summit Biosciences Comparisons
Industry
Financing
Details
Summit Biosciences Competitors (4)
One of Summit Biosciences’s 4 competitors is J Pharmaceuticals, a Corporation company based in Brookfield, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| J Pharmaceuticals | Corporation | Brookfield, WI | ||||
| Orasis Pharmaceuticals | Venture Capital-Backed | Ponte Vedra Beach, FL | ||||
| Similasan USA | Corporation | Highlands Ranch, CO | ||||
| ARS Pharmaceuticals | Formerly VC-backed | San Diego, CA |
Summit Biosciences Patents
Summit Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021217164-A1 | Drug products for intranasal administration and uses thereof | Active | 05-Feb-2020 | ||
| AU-2021217164-B2 | Drug products for intranasal administration and uses thereof | Active | 05-Feb-2020 | ||
| CA-3166250-A1 | Drug products for intranasal administration and uses thereof | Active | 05-Feb-2020 | ||
| EP-4100012-A1 | Drug products for intranasal administration and uses thereof | Active | 05-Feb-2020 | ||
| EP-4100012-A4 | Drug products for intranasal administration and uses thereof | Active | 05-Feb-2020 | A61K9/0043 |
Summit Biosciences Signals
Summit Biosciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Summit Biosciences FAQs
-
When was Summit Biosciences founded?
Summit Biosciences was founded in 2009.
-
Where is Summit Biosciences headquartered?
Summit Biosciences is headquartered in Lexington, KY.
-
What is the size of Summit Biosciences?
Summit Biosciences has 99 total employees.
-
What industry is Summit Biosciences in?
Summit Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Summit Biosciences a private or public company?
Summit Biosciences is a Private company.
-
What is Summit Biosciences’s current revenue?
The current revenue for Summit Biosciences is .
-
How much funding has Summit Biosciences raised over time?
Summit Biosciences has raised $3.2M.
-
Who are Summit Biosciences’s investors?
Kentucky Innovation Network, Keyhorse Capital, New Kentucky Home, and Yearling Management have invested in Summit Biosciences.
-
Who are Summit Biosciences’s competitors?
J Pharmaceuticals, Orasis Pharmaceuticals, Similasan USA, and ARS Pharmaceuticals are competitors of Summit Biosciences.
-
When was Summit Biosciences acquired?
Summit Biosciences was acquired on 18-Jan-2024.
-
Who acquired Summit Biosciences?
Summit Biosciences was acquired by Kindeva Drug Delivery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process